Medical applications of nanotechnology

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 69, Issue , 2015, Pages 1196-1204

  Zdrojewicz, Zygmunt ^a   Waracki, Mateusz ^a   Bugaj, Bartosz ^a   Pypno, Damian ^a   Cabała, Krzysztof ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Cancer treatment; Immunoprophylaxis; Nano knife; Nanomedicine; Nanostructures; Nanotechnology; Nanotubes

Indexed keywords

NANOMATERIAL;

ATHEROSCLEROSIS; DIAGNOSTIC IMAGING; HUMAN; NANOMEDICINE; NEOPLASMS; PROCEDURES;

ATHEROSCLEROSIS; DIAGNOSTIC IMAGING; HUMANS; NANOMEDICINE; NANOSTRUCTURES; NEOPLASMS;

EID: 84973408006     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.1177169     Document Type: Review

References (78)

1. Abiodun-Solanke I., Ajayi D., Arigbede A.: Nanotechnology and its application in dentistry. Ann. Med. Health Sci. Res., 2014; 4 (SUPPL. 3): 171-177
2. Ahn H.S., Hwang J.Y., Kim M.S., Lee J.Y., Kim J.W., Kim H.S., Shin U.S., Knowles J.C., Kim H.W., Hyun J.K.: Carbon-nanotube-interfaced glass fiber scaffold for regeneration of transected sciatic nerve. Acta Biomater., 2015; 13: 324-334
3. Akagi T., Wang X., Uto T., Baba M., Akashi M.: Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives. Biomaterials, 2007; 28: 3427-3436
4. Akbarzadeh A., Rezaei-Sadabady R., Davaran S., Joo S.W., Zarghami N., Hanifehpour Y., Samiei M., Kouhi M., Nejati-Koshki K.: Liposome: classification, preparation, and applications. Nanoscale Res. Lett. 2013;8:12
5. Banchereau J., Steinman R.M.: Dendritic cells and the control of immunity. Nature, 1998; 392: 245-252
6. Bangham A.D., Horne R.W.: Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J. Mol. Biol., 1964; 8: 660-668
7. Bansal S., Bansal M., Kumria R.: Nanocrystals: current strategies and trends. Int. J. Res. Pharm. Biomed. Sci., 2012; 3: 406-419
8. Bruchez M. Jr., Moronne M., Gin P., Weiss S., Alivisatos A.P.: Semiconductor nanocrystals as fluorescent biological labels. Science, 1998; 281: 2013-2016
9. Cai S., Yang Q., Bagby T.R., Forrest M.L.: Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles. Adv. Drug Deliv. Rev., 2011; 63: 901-908
10. Chaudhury K., Kumar V., Kandasamy J., Roy Choudhury S.: Regenerative nanomedicine: current perspectives and future directions. Int. J. Nanomedicine, 2014; 9: 4153-4167
11. Chen W., Xiong Q., Ren Q., Guo Y., Li G.: Can amino-functionalized carbon nanotubes carry functional nerve growth factor? Neural Regen. Res., 2014; 9: 285-292
12. Chow E.K., Ho D.: Cancer nanomedicine: from drug delivery to imaging. Sci. Transl. Med., 2013; 5: 216rv4
13. Cirillo G., Hampel S., Spizzirri U.G., Parisi O.I., Picci N., Iemma F.: Carbon nanotubes hybrid hydrogels in drug delivery: a perspective review. Biomed. Res. Int., 2014; 2014: 825017
14. Das S., Chaudhury A.: Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS Pharm-SciTech., 2011; 12: 62-76
15. Dobosz K.: Nanotechnology in computer programming. Studia Informatica, 2002; 23: 59-66
16. Eisele R.M., Chopra S.S., Glanemann M., Gebauer B.: Risk of local failure after ultrasound guided irreversible electroporation of malignant liver tumors. Interv. Med. Appl. Sci., 2014; 6: 147-153
17. Elamanchili P., Diwan M., Cao M. Samuel J.: Characterization of poly(D, L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells. Vaccine, 2004; 22: 2406-2412
18. Foged C., Brodin B., Frokjaer S., Sundblad A.: Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int. J. Pharm., 2005; 298: 315-322
19. Fredman G., Kamaly N., Spolitu S., Milton J., Ghorpade D., Chiasson R., Kuriakose G., Perretti M., Farokhzad O., Tabas I.: Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice. Sci. Transl. Med., 2015; 7: 275ra20
20. Freitas R.A.: Nanomedicine, volume I: Basic Capabilities. Landes Bioscience, Georgetown, TX 1999; 31
21. Gamvrellis A., Leong D., Hanley J.C., Xiang S.D., Mottram P., Plebanski M.: Vaccines that facilitate antigen entry into dendritic cells. Immunol. Cell Biol., 2004; 82: 506-516
22. Gao L., Liu G., Ma J., Wang X., Zhou L., Li X.: Drug nanocrystals: in vivo performances. J. Control. Release, 2012; 160: 418-430
23. Gao L., Liu G., Ma J., Wang X., Zhou L., Li X., Wang F.: Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs. Pharm. Res., 2013; 30: 307-324
24. Gregoriadis G.: Drug entrapment in liposomes. FEBS Lett., 1973; 36: 292-296
25. Gregoriadis G., Bacon A., Caparros-Wanderley W., McCormack B.: A role for liposomes in genetic vaccination. Vaccine, 2002; 20 (SUPPL. 5): B1-B9
26. Gregory A.E., Titball R., Williamson D.: Vaccine delivery using nanoparticles. Front. Cell. Infect. Microbiol., 2013; 3: 13
27. Hamouda T., Chepurnov A., Mank N., Knowlton J., Chepurnova T., Myc A., Sutcliffe J., Baker J.R. Jr.: Efficacy, immunogenicity and stability of a novel intranasal nanoemulsion-adjuvanted influenza vaccine in a murine model. Hum. Vaccin., 2010; 6: 585-594
28. Hamouda T., Myc A., Donovan B., Shih A.Y., Reuter J.D., Baker J.R. Jr.: A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi. Microbiol. Res., 2001; 156: 1-7
29. Holzinger M., Le Goff A., Cosnier S.: Nanomaterials for biosensing applications: a review. Front. Chem., 2014; 2: 63
30. Hwang J.Y., Shin U.S., Jang W.C., Hyun J.K., Wall I.B., Kim H.W.: Biofunctionalized carbon nanotubes in neural regeneration: a minireview. Nanoscale, 2013; 5: 487-497
31. Junghanns J.U., Müller R.H.: Nanocrystal technology, drug delivery and clinical applications. Int. J. Nanomedicine, 2008; 3: 295-309
32. Khanbabaie R., Jahanshahi M.: Revolutionary impact of nano-drug delivery on neuroscience. Curr. Neuropharmacol., 2012; 10: 370-392
33. Kim H., Uto T., Akagi, T., Baba M., Akashi M.: Amphiphilic poly(amino acid) nanoparticles induce size-dependent dendritic cell maturation. Adv. Funct. Mater, 2010; 20: 3925-3931
34. Klonoff D.C.: Overview of fluorescence glucose sensing: a technology with a bright future. J. Diabetes Sci. Technol., 2012; 6: 1242-1250
35. Kolosnjaj J., Szwarc H., Moussa F.: Toxicity studies of carbon nanotubes. Adv. Exp. Med. Biol., 2007; 620: 181-204
36. Kondratowicz J., Burczyk E.: Nanotechnologia w towaroznaw-stwie żywności. Chłodnictwo, 2008; 43: 50-53
37. Kraft J.C., Freeling J.P., Wang Z., Ho R.J.: Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. J. Pharm. Sci., 2014; 103: 29-52
38. Langauer-Lewowicka H., Pawlas K.: Nanoparticles, nanotechnology - potential environmental and occupational hazards. Med. Środow., 2014; 17: 7-14
39. Lee E.W., Thai S., Kee S.T.: Irreversible electroporation: a novel image-guided cancer therapy. Gut Liver, 2010; 4 (Suppl.1): 99-104
40. Leoni G., Neumann P.A., Kamaly N., Quiros M., Nishio H., Jones H.R., Sumagin R., Hilgarth R.S., Alam A., Fredman G., Argyris I., Rijcken E., Kusters D., Reutelingsperger C., Perretti M., et al.: Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair. J. Clin. Invest., 2015; 125: 1215-1227
41. Liu Y., Zhao Y., Sun B., Chen C.: Understanding the toxicity of carbon nanotubes. Acc. Chem. Res., 2013; 46: 702-713
42. Lohcharoenkal W., Wang L., Chen Y.C., Rojanasakul Y.: Protein nanoparticles as drug delivery carriers for cancer therapy. Biomed. Res. Int., 2014; 2014, 180549
43. Loo C., Lin A., Hirsch L., Lee M.H., Barton J., Halas N., West J., Drezek R.: Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol. Cancer Res. Treat., 2004; 3: 33-40
44. Lowery A.R., Gobin A.M., Day E.S., Halas N.J., West J.L.: Immunonanoshells for targeted photothermal ablation of tumor cells. Int. J. Nanomedicine, 2006; 1: 149-154
45. Lutsiak M.E., Robinson D.R., Coester C., Kwon G.S., Samuel J.: Analysis of poly(D, L-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro. Pharm. Res., 2002; 19: 1480-1487
46. Makidon P.E., Bielinska A.U., Nigavekar S.S., Janczak K.W., Knowlton J., Scott A.J., Mank N., Cao Z., Rathinavelu S., Beer M.R., Wilkinson J.E., Blanco L.P, Landers J.J., Baker J.R. Jr.: Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine. PLoS One, 2008; 3: e2954
47. Markman J.L., Rekechenetskiy A., Holler E., Ljubimova J.Y.: Nanomedicine therapeutic approaches to overcome cancer drug resistance. Adv. Drug Deliv. Rev., 2013; 65: 1866-1879
48. Martins S., Sarmento B., Ferreira D.C., Souto E.B.: Lipid-based colloidal carriers for peptide and protein delivery - liposomes versus lipid nanoparticles. Int. J. Nanomedicine, 2007; 2: 595-607
49. Michałowski W., Michałowska J.: Nanotechnologia we włókiennictwie. Przegląd Włókienniczy - Włókno, Odzież, Skóra, 2005; 2: 53-54
50. Mir L.M., Belehradek M., Domenge C., Orlowski S., Poddevin B., Belehradek J. Jr., Schwaab G., Luboinski B., Paoletti C.: Electrochemotherapy, a novel antitumor treatment: first clinical trial. C. R. Acad. Sci. III, 1991; 313: 613-618
51. Monthioux M., Kuznetsov V.L.: Who should be given the credit for the discovery of carbon nanotubes? Carbon, 2006; 44: 1621-1623
52. Morton J.G., Day E.S., Halas N.J., West J.L.: Nanoshells for photothermal cancer therapy. Methods Mol. Biol., 2010; 624: 101-117
53. Neumann E., Schaefer-Ridder M., Wang Y., Hofschneider P.H.: Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J., 1982; 1: 841-845
54. Putzbach W., Ronkainen N.J.: Immobilization techniques in the fabrication of nanomaterial-based electrochemical biosensors: a review. Sensors, 2013; 13: 4811-4840
55. Radushkevich L.V., Lukyanovich V.M.: O strukture ugleroda, obrazujucegosja pri termiceskom razlozenii okisi ugleroda na zeleznom kontakte. Zurn. Fisic. Chim., 1952; 26: 88-95
56. Reiss P., Protière M., Li L.: Core/Shell semiconductor nanocrystals. Small, 2009; 5: 154-168
57. Ross K.A., Loyd H., Wu W., Huntimer L., Ahmed S., Sambol A., Broderick S., Flickinger Z., Rajan K., Bronich T., Mallapragada S., Wannemuehler M.J., Carpenter S., Narasimhan B.: Hemagglutinin-based polyanhydride nanovaccines against H5N1 influenza elicit protective virus neutralizing titers and cell-mediated immunity. Int. J. Nanomedicine, 2015; 10: 229-243
58. Rubinsky B., Onik G., Mikus P.: Irreversible electroporation: a new ablation modality - clinical implications. Technol. Cancer Res. Treat., 2007; 6: 37-48
59. Saeed M.I., Omar A.R., Hussein M.Z., Elkhidir I.M., Sekawi Z.: Systemic antibody response to nano-size calcium phospate biocompatible adjuvant adsorbed HEV-71 killed vaccine. Clin. Exp. Vaccine Res., 2015; 4: 88-98
60. Sȩkowski S., Miłowska K., Gabryelak T.: Dendrimers in biomedical sciences and nanotechnology. Postȩpy Hig. Med. Dośw., 2008; 62: 725-733
61. Silk M.T., Wimmer T., Lee K.S., Srimathveeravalli G., Brown K.T., Kingham P.T., Fong Y., Durack J.C., Sofocleous C.T., Solomon S.B.: Percutaneous ablation of peribiliary tumors with irreversible electroporation. J. Vasc. Interv. Radiol., 2014; 25: 112-118
62. 805EC combined with approved seasonal influenza antigens. Vaccine, 2012; 30: 307-316
63. Stankiewicz N., Lelusz M.: Nanotechnology in civil engineering - application review. Budownictwo i Inżynieria Środowiska, 2014; 5: 101-112
64. Svenson S., Tomalia D.A.: Dendrimers in biomedical applications - reflections on the field. Adv. Drug Deliv. Rev., 2005; 57: 2106-2129
65. Świderski F., Waszkiewicz-Robak B.: Nanotechnology the present and the future. Postȩpy Techniki Przetwórstwa Spożywczego, 2006; 16: 55-57
66. Tahamtan A., Ghaemi A., Gorji A., Kalhor H.R., Sajadian A., Tabarraei A., Moradi A., Atyabi F., Kelishadi M.: Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems. J. Biomed. Sci., 2014; 21: 69
67. Thivierge M., Stankova J., Rola-Pleszczynski M.: Toll-like receptor agonists differentially regulate cysteinyl-leukotriene receptor 1 expression and function in human dendritic cells. J. Allergy Clin. Immunol., 2006; 117: 1155-1162
68. Tomalia D.A., Baker H., Dewald J., Hall M., Kallos G., Martin S., Roeck J., Ryder J., Smith P.: A new class of polymers: starburst-dendritic macromolecules. Polymer J., 1985; 17: 117-132
69. Tomalia D.A., Fréchet J.M.: Discovery of dendrimers and dendritic polymers: a brief historical perspective. J. Polymer Sci. Part A: Polymer Chemistry, 2002; 40: 2719-2728
70. Tsoi K.M., Dai Q., Alman B.A., Chan W.C.: Are quantum dots toxic? Exploring the discrepancy between cell culture and animal studies. Acc. Chem. Res., 2013; 46: 662-671
71. Valerio M., Stricker P.D., Ahmed H.U., Dickinson L., Ponsky L., Shnier R., Allen C., Emberton M.: Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer. Prostate Cancer Prostatic Dis., 2014; 17: 343-347
72. Webster T.J.: IJN's second year is now a part of nanomedicine history! Int. J. Nanomedicine, 2007; 2: 1-2
73. Wojnicz R.: Nanomedicine as the basis of personalised medicine. Kardiol. Pol., 2011; 69: 1107-1108
74. World Health Organization. The top 10 causes of death. http://www.who.int/mediacentre/factsheets/fs310/en/ (13.07.2015)
75. Zdrojewicz Z., Pypno D., Cabała K., Bugaj B., Waracki M.: Potential applications of marijuana and cannabinoids in medicine. Pol. Merkur. Lekarski, 2014; 37: 248-252
76. Zhang X.: Gold nanoparticles: recent advances in the biomedical applications. Cell Biochem. Biophys., 2015; 7: 771-775
77. Zhang X.D., Wu D., Shen X., Liu P.X., Yang N., Zhao B., Zhang H., Sun Y.M., Zhang L.A., Fan F.Y.: Size-dependent in vivo toxicity of PEG-coated gold nanoparticles. Int. J. Nanomedicine, 2011; 6: 2071-2081
78. Zhu M., Wang R., Nie G.: Applications of nanomaterials as vaccine adjuvants. Hum. Vaccin. Immunother., 2014; 10: 2761-2774